| Nadine Sadia Laila, OD | |
|
26140 Ingersol Dr, Novi, MI 48375-1213 | |
| (248) 348-2900 | |
| Not Available |
| Full Name | Nadine Sadia Laila |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 4 Years |
| Location | 26140 Ingersol Dr, Novi, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730702689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT.006898 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fortney Eyecare Associates Inc | 6507816584 | 2 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
Australian researchers have developed the country's first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.
Marking the 10th anniversary of the landmark federal act that encouraged hospitals, clinics, and physician offices to adopt electronic health record systems, MedStar Health experts in patient safety and health information technology are collaborating with the American Medical Association to push for changes to address the known risks to patient safety and clinician burnout that stem from poor EHR usability.
The University of Ottawa has been awarded four new Canada Research Chairs (CRC) that will strengthen its expertise in artificial intelligence, health and law.
› Verified 7 days ago
| Provider Name | Fortney Eyecare Associates Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508970310 PECOS PAC ID: 6507816584 Enrollment ID: O20050127000371 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
Australian researchers have developed the country's first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.
Marking the 10th anniversary of the landmark federal act that encouraged hospitals, clinics, and physician offices to adopt electronic health record systems, MedStar Health experts in patient safety and health information technology are collaborating with the American Medical Association to push for changes to address the known risks to patient safety and clinician burnout that stem from poor EHR usability.
The University of Ottawa has been awarded four new Canada Research Chairs (CRC) that will strengthen its expertise in artificial intelligence, health and law.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nadine Sadia Laila, OD 26140 Ingersol Dr, Novi, MI 48375-1213 Ph: () - | Nadine Sadia Laila, OD 26140 Ingersol Dr, Novi, MI 48375-1213 Ph: (248) 348-2900 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
Australian researchers have developed the country's first diabetes specific stem cell line, a major advance for patients suffering from the chronic disease.
Marking the 10th anniversary of the landmark federal act that encouraged hospitals, clinics, and physician offices to adopt electronic health record systems, MedStar Health experts in patient safety and health information technology are collaborating with the American Medical Association to push for changes to address the known risks to patient safety and clinician burnout that stem from poor EHR usability.
The University of Ottawa has been awarded four new Canada Research Chairs (CRC) that will strengthen its expertise in artificial intelligence, health and law.
› Verified 7 days ago
Caroline J Sippala, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27380 Novi Rd, Novi, MI 48377 Phone: 248-344-1044 | |
Austin Ayad Kashat, OD Optometrist Medicare: Medicare Enrolled Practice Location: 47300 W 10 Mile Rd, Novi, MI 48374 Phone: 248-782-2777 Fax: 810-295-2605 | |
Clearview Eyecare, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 45075 W Pontiac Trl, Novi, MI 48377 Phone: 248-960-5600 Fax: 248-960-8049 | |
Rimsha Zaman Choudhry, OD Optometrist Medicare: Medicare Enrolled Practice Location: 26425 Novi Rd Ste D, Novi, MI 48375 Phone: 248-344-1426 Fax: 248-344-1530 | |
Dr. Reeta Raina, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27838 Novi Rd, Novi, MI 48377 Phone: 248-348-2900 Fax: 248-344-0908 | |
Carolyn Louise Easter, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 27380 Novi Rd, Novi, MI 48377 Phone: 248-344-1044 | |
Denise Wilson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 27300 Wixom Rd, Novi, MI 48374 Phone: 248-349-6379 |